National Commodity & Derivatives Exchange (NCDEX) Unlisted Shares
NCDEX secures ₹500 cr funding, Citadel and Tower Research among investors
Business Standard
2 min read
NCDEX Secures Rs 500 Crore Funding for Equity Market Entry.
Expert Analysis:
Funding Secured: NCDEX has raised over Rs 500 crore from investors including Citadel Securities, Tower Research, Acacia Partners, Groww, Kotak Life Insurance, and JM Financial.
Fundraising Target: The exchange aims to raise Rs 750 crore, with proceeds earmarked exclusively for building its equities business.
Investor Commitments: Citadel Securities and Tower Research committed Rs 17 crore and Rs 34 crore respectively for minority stakes.
Board Approval and Market Outlook: NCDEX’s funding commitments were discussed in its board meeting and will go to shareholders for approval on September 1, with experts highlighting strong profitability and investor appeal in Indian exchanges despite regulatory curbs on speculation.
Shareholding Impact: Fresh funding will dilute existing institutional investors including LIC, NABARD, and Punjab National Bank.
Launch Timeline: CEO Arun Raste stated NCDEX expects SEBI’s final approval by fiscal-end, targeting an August launch starting with cash, then derivatives.
Fresh Rs 500 crore funding, credible institutional backing, and SEBI approval progress position NCDEX’s equities for strong long-term investor value.
Precize Daily Pulse
The latest news in the world of Unlisted Shares, summarised by our experts.
Company
Our Office
Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093
Find us on Googlesupport@precize.in
+91 7738336457
All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.
The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.
Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.
The website will be updated regularly.
Copyright © 2026 - Precize - All Rights Reserved